New York, NY, United States of America

Pedro J Real

This inventor holds 1 USPTO granted patent. Top assignee: Columbia University. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pedro J Real. Retrieved from https://idiyas.com/inventor/pedro-j-real

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pedro J. Real: Inventor in Biomedical Research

Introduction

Pedro J. Real is an inventor associated with Columbia University in New York, NY. His patent work concerns potential therapeutic approaches involving NOTCH-1 inhibitors and glucocorticoids.

Latest Patents

The supplied information identifies one patent associated with Real: “Synergistic Interaction of NOTCH-1 Inhibitors with Glucocorticoids.” The invention describes methods and compositions intended to prevent or treat conditions including T-cell lymphoblastic leukemia and lymphoma, as well as neurodegenerative diseases such as Alzheimer’s disease. One approach combines a NOTCH-1 inhibitor with a glucocorticoid. The patent also describes using NOTCH-1 inhibitors to improve glucocorticoid efficacy and mitigate resistance in treating T-cell lymphoblastic leukemia and lymphoma. The supplied record lists 1 patent.

Career Highlights

Real’s listed patent reflects research focused on the therapeutic potential of targeting NOTCH-1 pathways and combining treatments. The information provided associates his work with Columbia University.

Collaborations

Adolfo A. Ferrando is listed as Real’s coworker. The patent information provided describes research relevant to leukemia and lymphoma treatment, but does not specify the individual contributions of the listed collaborators.

Conclusion

Pedro J. Real’s listed invention explores how NOTCH-1 inhibitors may complement glucocorticoids in treating cancer and other conditions, highlighting a potential direction for therapeutic research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…